Seth Uretsky1, Edgar Argulian2, Azhar Supariwala3, Shiv K Agarwal4, Georges El-Hayek2, Patricia Chavez2, Hira Awan2, Ashadevi Jagarlamudi2, Siva P Puppala2, Randy Cohen2, Alan Rozanski2. 1. Department of Cardiovascular Medicine, Morristown Medical Center, Gagnon Cardiovascular Institute, 100 Madison Ave, Morristown, NJ, 07960, USA. uretss02@yahoo.com. 2. Division of Cardiology, Department of Medicine, Mount Sinai St. Luke's Hospital, New York, NY, USA. 3. Northshore LIJ Southside Hospital, Hofstra School of Medicine, NSLIJHS, Bayshore, NY, USA. 4. Department of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Abstract
BACKGROUND: Because the frequency of cardiac event rates is low among chest pain patients following either performance of coronary CT angiography (CCTA) or stress testing, there is a need to better assess how these tests influence the central management decisions that follow from cardiac testing. The present study was performed to assess the relative impact of CCTA vs stress testing on medical therapies and downstream resource utilization among patients admitted for the work-up of chest pain. METHODS: The admitted patients were randomized in a 1:1 ratio to either cardiac imaging stress test or CCTA. Primary outcomes were time to discharge, change in medication usage, and frequency of downstream testing, cardiac interventions, and cardiovascular re-hospitalizations. We randomized 411 patients, 205 to stress testing, and 206 to CCTA. RESULTS: There were no differences in time to discharge or initiation of new cardiac medications at discharge. At 1 year follow-up, there was no difference in the number of patients who underwent cardiovascular downstream tests in the CCTA vs stress test patients (21% vs 15%, P = .1) or cardiovascular hospitalizations (14% vs 16%, P = .5). However, there was a higher frequency of invasive angiography in the CCTA group (11% vs 2%, P = .001) and percutaneous coronary interventions (6% vs 0%, P < .001). CONCLUSIONS: Randomization of hospitalized patients admitted for chest pain work-up to eitherCCTA or to stress testing resulted in similar discharge times, change in medical therapies at discharge, frequency of downstream noninvasive testing, and repeat hospitalizations. However, a higher frequency of invasive coronary angiography and revascularization procedures were performed in the CCTA arm. (ClinicalTrials.gov number, NCT01604655.).
RCT Entities:
BACKGROUND: Because the frequency of cardiac event rates is low among chest painpatients following either performance of coronary CT angiography (CCTA) or stress testing, there is a need to better assess how these tests influence the central management decisions that follow from cardiac testing. The present study was performed to assess the relative impact of CCTA vs stress testing on medical therapies and downstream resource utilization among patients admitted for the work-up of chest pain. METHODS: The admitted patients were randomized in a 1:1 ratio to either cardiac imaging stress test or CCTA. Primary outcomes were time to discharge, change in medication usage, and frequency of downstream testing, cardiac interventions, and cardiovascular re-hospitalizations. We randomized 411 patients, 205 to stress testing, and 206 to CCTA. RESULTS: There were no differences in time to discharge or initiation of new cardiac medications at discharge. At 1 year follow-up, there was no difference in the number of patients who underwent cardiovascular downstream tests in the CCTA vs stress test patients (21% vs 15%, P = .1) or cardiovascular hospitalizations (14% vs 16%, P = .5). However, there was a higher frequency of invasive angiography in the CCTA group (11% vs 2%, P = .001) and percutaneous coronary interventions (6% vs 0%, P < .001). CONCLUSIONS: Randomization of hospitalized patients admitted for chest pain work-up to either CCTA or to stress testing resulted in similar discharge times, change in medical therapies at discharge, frequency of downstream noninvasive testing, and repeat hospitalizations. However, a higher frequency of invasive coronary angiography and revascularization procedures were performed in the CCTA arm. (ClinicalTrials.gov number, NCT01604655.).
Authors: Harold I Litt; Constantine Gatsonis; Brad Snyder; Harjit Singh; Chadwick D Miller; Daniel W Entrikin; James M Leaming; Laurence J Gavin; Charissa B Pacella; Judd E Hollander Journal: N Engl J Med Date: 2012-03-26 Impact factor: 91.245
Authors: Michael Poon; Michael Cortegiano; Alexander J Abramowicz; Margaret Hines; Adam J Singer; Mark C Henry; Peter Viccellio; Jeffrey C Hellinger; Summer Ferraro; Annie Poon; Gilbert L Raff; Szilard Voros; Michael E Farkouh; Pamela Noack Journal: J Am Coll Cardiol Date: 2013-05-15 Impact factor: 24.094
Authors: Leslee J Shaw; Daniel S Berman; Michael H Picard; Matthias G Friedrich; Raymond Y Kwong; Gregg W Stone; Roxy Senior; James K Min; Rory Hachamovitch; Marielle Scherrer-Crosbie; Jennifer H Mieres; Thomas H Marwick; Lawrence M Phillips; Farooq A Chaudhry; Patricia A Pellikka; Piotr Slomka; Andrew E Arai; Ami E Iskandrian; Timothy M Bateman; Gary V Heller; Todd D Miller; Eike Nagel; Abhinav Goyal; Salvador Borges-Neto; William E Boden; Harmony R Reynolds; Judith S Hochman; David J Maron; Pamela S Douglas Journal: JACC Cardiovasc Imaging Date: 2014-06
Authors: Seth Uretsky; Alan Rozanski; Azhar Supariwala; Surinder Khokhar; Prashanth Atluri; Salim Memon; George Dangas; Edward A Fisher; Steven D Wolff; M Robert Peters Journal: Coron Artery Dis Date: 2011-11 Impact factor: 1.439
Authors: James A Goldstein; Michael J Gallagher; William W O'Neill; Michael A Ross; Brian J O'Neil; Gilbert L Raff Journal: J Am Coll Cardiol Date: 2007-02-12 Impact factor: 24.094
Authors: Su Min Chang; Faisal Nabi; Jiaqiong Xu; Leif E Peterson; Arup Achari; Craig M Pratt; John J Mahmarian Journal: J Am Coll Cardiol Date: 2009-11-10 Impact factor: 24.094
Authors: Edward Hulten; Christopher Pickett; Marcio Sommer Bittencourt; Todd C Villines; Sara Petrillo; Marcelo F Di Carli; Ron Blankstein Journal: J Am Coll Cardiol Date: 2013-02-06 Impact factor: 24.094
Authors: Michael C Honigberg; Bradley S Lander; Vinit Baliyan; Maeve Jones-O'Connor; Emma W Healy; Jan-Erik Scholtz; John T Nagurney; Udo Hoffmann; Brian B Ghoshhajra; Pradeep Natarajan Journal: JACC Cardiovasc Imaging Date: 2019-07-17
Authors: Gianluca Pontone; Alexia Rossi; Marco Guglielmo; Marc R Dweck; Oliver Gaemperli; Koen Nieman; Francesca Pugliese; Pal Maurovich-Horvat; Alessia Gimelli; Bernard Cosyns; Stephan Achenbach Journal: Eur Heart J Cardiovasc Imaging Date: 2022-02-22 Impact factor: 6.875
Authors: Andrew J Foy; Sanket S Dhruva; Brandon Peterson; John M Mandrola; Daniel J Morgan; Rita F Redberg Journal: JAMA Intern Med Date: 2017-11-01 Impact factor: 21.873